NCT04198922: Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease |
|
|
| Recruiting | 2 | 50 | US | Acalabrutinib, 1420477-60-6, ACP-196, Benzamide, Bruton Tyrosine Kinase Inhibitor ACP-196, Questionnaire Administration | Fred Hutchinson Cancer Center, AstraZeneca | Recurrent Moderate-Severe Chronic Graft Versus Host Disease, Hematopoietic and Lymphoid Cell Neoplasm | 12/25 | 01/27 | | |
NCT05996627: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease |
|
|
| Recruiting | 2 | 82 | US | Belumosudil, KD 025, KD-025, KD025, Rho-associated Coiled-coil Kinase 2 Inhibitor KD025, ROCK-II Inhibitor KD025, ROCK2 Inhibitor KD025, SLx 2119, SLx-2119, SLx2119, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Electronic Health Record Review, Placebo Administration | Fred Hutchinson Cancer Center, Sanofi | Chronic Graft Versus Host Disease | 05/27 | 12/27 | | |
NCT04111497: Glasdegib for Chronic Graft-Versus-Host Disease |
|
|
| Terminated | 1/2 | 15 | US | Glasdegib, 1095173-27-5, PF 04449913, PF-04449913, PF04449913 | Fred Hutchinson Cancer Center, Pfizer | Chronic Graft Versus Host Disease, Fasciitis | 08/23 | 08/23 | | |
NCT06202677: Effectiveness of a Self-guided Mobile Application in Improving Obsessive Compulsive Disorder Symptoms |
|
|
| Active, not recruiting | N/A | 225 | RoW | Self-guided program on obsessive compulsive disorder, Self-guided program on cooperation | National University of Singapore, Intellect Pte. Ltd. | Obsessive-Compulsive Disorder | 03/24 | 07/24 | | |
